Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OCUL - OCULAR THERAPEUTIX, INC


IEX Last Trade
8.55
-0.040   -0.468%

Share volume: 11,956
Last Updated: Fri 27 Dec 2024 02:30:10 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 1.34%

PREVIOUS CLOSE
CHG
CHG%

$8.59
-0.04
-0.47%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-08 2022-11-07 2023-03-06 2023-05-08 2023-08-07 2023-11-07 2024-03-11 2024-05-07
Total revenue 12.266 M 11.965 M 14.076 M 13.374 M 15.186 M 15.081 M 14.802 M 14.774 M
Cost of revenue 1.155 M 1.073 M 1.012 M 1.214 M 1.304 M 1.377 M 1.386 M 1.326 M
Gross profit 11.111 M 10.892 M 13.064 M 12.160 M 13.882 M 13.704 M 13.416 M 13.448 M
    -1.97% 19.94% -6.92% 14.16% -1.28% -2.10% 0.24%  
Operating expenses 31.027 M 32.436 M 32.425 M 34.709 M 34.452 M 32.918 M 33.465 M 45.065 M
Selling general and admin 17.927 M 18.717 M 18.882 M 19.962 M 19.358 M 17.899 M 17.270 M 24.330 M
Research and development 13.100 M 13.719 M 13.543 M 14.747 M 15.094 M 15.019 M 16.195 M 20.735 M
Total expenses 32.182 M 33.509 M 33.437 M 35.923 M 35.756 M 34.295 M 34.851 M 46.391 M
    4.12% -0.21% 7.43% -0.46% -4.09% 1.62% 33.11%  
Operating income -19.916 M -21.544 M -19.361 M -22.549 M -20.570 M -19.214 M -20.049 M -31.617 M
Ebit -19.916 M -21.544 M -19.361 M -22.549 M -20.570 M -19.214 M -20.049 M -31.617 M
Pretax income -18.766 M -24.188 M -15.542 M -30.318 M -20.682 M -516.000 K -29.220 M -64.848 M
    28.89% -35.74% 95.07% -31.78% -97.51% 5,562.79% 121.93%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -18.766 M -24.188 M -15.542 M -30.318 M -20.682 M -516.000 K -29.220 M -64.848 M
    -28.89% 35.74% -95.07% 31.78% 97.51% -5,562.79% -121.93%  
Net income -18.766 M -24.188 M -15.542 M -30.318 M -20.682 M -516.000 K -29.220 M -64.848 M
    -28.89% 35.74% -95.07% 31.78% 97.51% -5,562.79% -121.93%